The EV-D68 virus has only been confirmed in six states, but another 15 states are reporting clusters of respiratory illness they suspect may be due to this rarely seen enterovirus, and are awaiting test results (see CDC EV-D68 Update & FAQ). EV-D68 is not a `reportable’ illness, and so it is likely the virus is more widespread than official reports thus far indicate.
While most who contract this respiratory infection will experience nothing worse than a bad `cold’, some serious illnesses have been reported – particularly among children with asthma.
Late Friday night the CDC issued a HAN (Health Alert Network) Advisory on the outbreak (see CDC HAN Advisory On EV-D68) and tomorrow afternoon the CDC will hold a COCA Call as well. Although primarily of interest to clinicians, the CDC holds frequent COCA (Clinician Outreach Communication Activity) calls which are designed to ensure that practitioners have up-to-date information for their practices.
Date:Tuesday, September 16, 2014
Time:2:00 – 3:00 PM (Eastern Time)
Participate by phone
Audio Bridge Line:
- 888-995-9727 (U.S. Callers)
- 210-234-0034 (International Callers)
Susan Gerber, MD
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases - CDC
Mary Anne Jackson, MD, FAAP
Division Director, Infectious Disease
Children’s Mercy Hospital & Clinics
Professor of Pediatrics
University of Missouri-Kansas City School of Medicine
Daniel Johnson, MD, FAAP
Associate Professor of Pediatrics
University of Chicago Medicine
Comer Children’s Hospital
Hospitals across the U.S., especially in Missouri and Illinois, are seeing more children with severe respiratory illness caused by enterovirus D68 (EV-D68). Several states are also investigating similar clusters of severe respiratory illness. There are no vaccines for preventing EV-D68 infections. Clinicians should consider EV-D68 as a potential cause of clusters of severe respiratory illness, particularly in children. During this COCA call, clinicians will learn about the current EV-D68 situation in the U.S., laboratory testing, reporting suspected clusters, and approaches to prevention and treatment.
At the conclusion of the session, the participant will be able to accomplish the following:
- Discuss the current EV-D68 situation in the United States, including clusters in Missouri and Illinois
- Describe the procedures for laboratory testing and reporting clusters of suspected cases
- Explain prevention and treatment strategies to address EV-D68